3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
6
Peritoneal Neoplasms
6
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Colorectal Neoplasms
3
Pancreatic Neoplasms
2
Neoplasms
2
Gastric Adenocarcinoma
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Appendiceal Neoplasms
2
Uterine Neoplasms
1
Stomach Diseases
1
Pseudomyxoma Peritonei
1
Ovarian Epithelial Cancer Recurrent
1
Locally Advanced Gastric Cancer
1
Krukenberg Tumor
1
HIPEC
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Gastric Cancer Peritoneal Metastases
1
Digestive System Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Interventions
pembrolizumab
12
Pemetrexed
9
Cisplatin
9
Nivolumab
8
Carboplatin
8
Ipilimumab
7
Cyclophosphamide
6
fludarabine
5
durvalumab
4
tremelimumab
2
Radiotherapy, Intensity-Modulated
2
Gemcitabine
2
Cerebral Decortication
2
tocilizumab
1
tislelizumab
1
tazemetostat
1
sotorasib
1
ruxolitinib
1
osimertinib
1
olaparib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
bintrafusp alfa protein, human
1
avelumab
1
atezolizumab
1
Tumor Burden
1
Tablets
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Hyperthermic Intraperitoneal Chemotherapy
×
1 year
×
Clear all
No trials found.